Alnylam Pharmaceuticals Q3 2016 Financial Results

Alnylam Pharmaceuticals presents third quarter 2016 financial results and corporate updates. The presentation covers Q3 overview, clinical pipeline developments, financial performance, and 2016 goal progress, along with forward-looking statements regarding drug discovery, regulatory approvals, and business strategy.